@queenofwealth:

Mmiridoroedo
Mmiridoroedo
Open In TikTok:
Region: NG
Tuesday 27 October 2026 13:22:53 GMT
9689
1064
144
12

Music

Download

Comments

terry.monei
༒☬NO PRESSURE☬༒ :
iseeeee[Hands open]
2026-10-29 22:48:26
0
alex.fundz33
Alex Fundz :
iseeeeeeeeeee 🙏🙏🙏🙏
2026-10-29 16:09:48
0
mrisrea
official Isreal :
iiiiiiiiissssssssseeeeeeeee
2026-10-29 16:11:42
0
jenny.baby59
EbyBest 👑🚿 :
iseeeeeeeeeeeee yagazie
2026-10-29 15:01:37
0
caro.baby38
caro baby 💞 :
iseeeeeeeeeeeeeeeee
2026-10-29 15:44:11
0
pcharles78
Charlie black :
I seeeeeeeee
2026-10-29 13:39:45
0
eaglebee2
DATING BOY ☑️🎉 :
iseeeeeeeeeeeeeeeeeeeeeeeeeeee 🙏🤲 lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee
2026-10-27 17:30:14
3
officialoshimiri
Empress Evie official :
iseeeeee yagazie
2026-10-27 19:20:30
3
deborah12912
De🥰bo🥳ra💘h :
iseeeeeeeeeeeeeeeeeeeeeeeeeeeeeee iseeeeeeeeeeeeeeeeeeeeeeeeeeeeeee iseeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
2026-10-27 19:48:52
2
user3226173261744
original :
iseee iseeeeeee iseeeeeeeeeeeeeeeeeeee
2026-10-27 20:11:34
1
doskiray1
꧁༒𝐃𝐎𝐒𝐊𝐈 𝐑𝐀𝐘༒꧂ :
iseeee
2026-10-30 08:17:38
0
buurkheucha10
light :
iseeeeeeee and iseeeeeeee and iseeeeeeee and iseeeeeeee
2026-10-27 14:26:22
1
chisomwasco
chisom wasco :
iseeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
2026-10-27 14:13:41
1
emmycoola
@🗽Emmy cool.🎤🎙️ :
iseeeeeeeeeeeeee iseeeeeee iseeeeeee
2026-10-27 20:21:02
1
itzhope149
itz hope oshios :
iseeeeeeeeeeeeeeeee
2026-10-27 13:39:06
1
miracle.obinna89
Miracle Obinna :
iseeeeeeeee iseeeeeeeee iseeeeeeeee iseeeeeeeee iseeeeeeeee iseeeeeeeee iseeeeeeeee iseeeeeeeee iseeeeeeeee iseeeeeeeee iseeeeeeeee
2026-10-27 20:41:27
0
promisetosucceed191
promise to succeed 🙏💪 :
iseeeeeeeeeeeeeeeeeeeeeeeeeeee 🙏🤲 lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee lseeeee
2026-10-27 19:25:26
1
onyi.dikeocha
Mmiri mma 🥰 :
iseeeee iseeeee iseeeee
2026-10-27 13:49:39
1
akuuchukwuka24
PriestessAkuuchukwu sanctuary :
iseeeeee iseeeee
2026-10-27 15:42:17
1
ezifule
mirie nsk :
iseeeeee óoooooo
2026-10-27 13:42:19
1
akachukwujohn679
Ṣūççëṣṣfül Ɓõƴ :
iseeee iseeee iseeee iseeee
2026-10-30 16:48:37
0
chrisdan356
Chris Dan :
Iseeeeeee iseeeeeee iseeeeeee iseeeeeee iseeeeeee iseeeeeee iseeeeeee 🤲🤲🤲🤲🤲🙏
2026-10-30 11:34:01
0
promise_dc00
promise_DC :
Iseeeeeeeee
2026-10-30 06:42:09
0
big_mike_x
⚡𝔹𝕚𝕘 𝕄𝕚𝕜𝕖⚡ :
iseeeeeee
2026-10-30 01:08:46
0
edobaby30
Edo baby 💕🥰☀️ :
Iseeeeeeeeeeeeeee
2026-10-30 13:59:32
0
To see more videos from user @queenofwealth, please go to the Tikwm homepage.

Other Videos

GLP-1 receptor agonists are known for diabetes and weight, but a fast-growing body of research suggests they’re also broadly anti-inflammatory and immune-modulating. A 2025 systematic review described effects well beyond metabolism, including emerging interest in autoimmune and neurological conditions. The most direct evidence for MCAS so far is a single 2025 retrospective case series: 47 patients with treatment-resistant MCAS, 89% of whom showed clinical benefit, often within hours to days, across inflammatory, gastrointestinal, neurologic, and autonomic symptoms. Mechanistically, mast cells carry GLP-1 receptors, and these drugs dampen inflammatory pathways like TNF-alpha and NF-kB, which may explain it. The limitations matter and the hype skips them: this was retrospective, single-group, with NO control or placebo, and the authors themselves state that randomized controlled trials are needed before any of this is established. GLP-1 medications are serious prescription drugs with real side effects, real costs, and access issues, and they are NOT a proven or standard MCAS treatment. This is a promising research lead, not a recommendation. I’m not a doctor or scientist. Talk to a clinician who knows your history. Has anyone here been on a GLP-1 and noticed other symptoms change? Curious what you actually experienced. Sources: Afrin LB, Weinstock LB, Dempsey TT, Aschenbrenner K, Blitshteyn S, Schofield JR. Utility of GLP-1 receptor agonists in mast cell activation syndrome. Am J Med Sci. 2025;370(4):377-382. DOI: 10.1016/j.amjms.2025.07.006. Patel S, Niazi SK. Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base. Pharmaceutics. 2025. DOI: 10.3390/pharmaceutics17081036. Alharbi SH. Anti-inflammatory role of GLP-1 receptor agonists and its clinical implications. Ther Adv Endocrinol Metab. 2024. DOI: 10.1177/20420188231222367. #mcas #mastcellactivationsyndrome #glp1 #semiglutide #autoimmune
GLP-1 receptor agonists are known for diabetes and weight, but a fast-growing body of research suggests they’re also broadly anti-inflammatory and immune-modulating. A 2025 systematic review described effects well beyond metabolism, including emerging interest in autoimmune and neurological conditions. The most direct evidence for MCAS so far is a single 2025 retrospective case series: 47 patients with treatment-resistant MCAS, 89% of whom showed clinical benefit, often within hours to days, across inflammatory, gastrointestinal, neurologic, and autonomic symptoms. Mechanistically, mast cells carry GLP-1 receptors, and these drugs dampen inflammatory pathways like TNF-alpha and NF-kB, which may explain it. The limitations matter and the hype skips them: this was retrospective, single-group, with NO control or placebo, and the authors themselves state that randomized controlled trials are needed before any of this is established. GLP-1 medications are serious prescription drugs with real side effects, real costs, and access issues, and they are NOT a proven or standard MCAS treatment. This is a promising research lead, not a recommendation. I’m not a doctor or scientist. Talk to a clinician who knows your history. Has anyone here been on a GLP-1 and noticed other symptoms change? Curious what you actually experienced. Sources: Afrin LB, Weinstock LB, Dempsey TT, Aschenbrenner K, Blitshteyn S, Schofield JR. Utility of GLP-1 receptor agonists in mast cell activation syndrome. Am J Med Sci. 2025;370(4):377-382. DOI: 10.1016/j.amjms.2025.07.006. Patel S, Niazi SK. Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base. Pharmaceutics. 2025. DOI: 10.3390/pharmaceutics17081036. Alharbi SH. Anti-inflammatory role of GLP-1 receptor agonists and its clinical implications. Ther Adv Endocrinol Metab. 2024. DOI: 10.1177/20420188231222367. #mcas #mastcellactivationsyndrome #glp1 #semiglutide #autoimmune

About